Insights

Market Expansion GVB Biopharma has a global footprint with facilities in Central Oregon and Las Vegas and a distribution presence in the Netherlands, indicating readiness for regional market expansion and channel partnerships in Europe and North America.

Vertical Integration Full controllership from farming to finished products enables end-to-end supply assurances and potential partnerships for private label programs, contract manufacturing, and custom formulations.

Product Innovation Recent CBT Isolate launch signals a focus on standardized cannabinoid ingredients suitable for partnerships with consumer brands seeking consistent actives for finished goods and APIs for regulated markets.

White Label Scale Established white-label manufacturing capability in a dedicated facility supports rapid on-brand product launches for retailers and D2C brands seeking turnkey hemp- and cannabinoid-containing products.

Quality & Compliance In-house testing and traceable quality control, combined with past API certification pursuits, position GVB as a reliable partner for brands requiring GMP-like reliability, robust documentation, and regulatory alignment.

Similar companies to GVB Biopharma

GVB Biopharma Tech Stack

GVB Biopharma uses 8 technology products and services including Hotjar, Linkedin Insight Tag, Snowplow, and more. Explore GVB Biopharma's tech stack below.

Media & News

GVB Biopharma's Email Address Formats

GVB Biopharma uses at least 2 email formats:
GVB Biopharma Email FormatsExamplePercentage
First@gvbbiopharma.comJohn@gvbbiopharma.com
84%
FLast@gvbbiopharma.comJDoe@gvbbiopharma.com
16%

Frequently Asked Questions

What is GVB Biopharma's official website and social media links?

Minus sign iconPlus sign icon
GVB Biopharma's official website is gvbbiopharma.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does GVB Biopharma generate?

Minus sign iconPlus sign icon
As of October 2026, GVB Biopharma's annual revenue is estimated to be $25M - $50M.

What is GVB Biopharma's SIC code and NAICS code?

Minus sign iconPlus sign icon
GVB Biopharma's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does GVB Biopharma have currently?

Minus sign iconPlus sign icon
As of October 2026, GVB Biopharma has approximately 56 employees across 4 continents, including North America, Asia and Europe. Key team members include Project Manager: D. M., Shipping Logistics: S. S. and Sales & Business Development Executive: S. B. Explore GVB Biopharma's employee directory with LeadIQ.

What industry does GVB Biopharma belong to?

Minus sign iconPlus sign icon
GVB Biopharma operates in the Biotechnology Research industry.

What technology does GVB Biopharma use?

Minus sign iconPlus sign icon
GVB Biopharma's tech stack includes Hotjar, Linkedin Insight Tag, Snowplow, Shopify, Google Workspace, Google Cloud, Intercom and Klaviyo.

What is GVB Biopharma's email format?

Minus sign iconPlus sign icon
GVB Biopharma's email format typically follows the pattern of First@gvbbiopharma.com. Find more GVB Biopharma email formats with LeadIQ.

How much funding has GVB Biopharma raised to date?

Minus sign iconPlus sign icon
As of October 2026, GVB Biopharma has raised $1.5M in funding. The last funding round occurred on Nov 02, 2021 for $1.5M.
GVB Biopharma logo

GVB Biopharma

Biotechnology ResearchNevada, United States51-200 Employees

GVB Biopharma is a biotechnology company focused on hemp and cannabinoid research that operates along the full value chain. It maintains vertical integration from cultivation through extraction and testing to formulation, supporting both raw materials and finished products. The company runs two facilities: a 30,000-square-foot hemp processing plant in Central Oregon and a 40,000-square-foot white-label product manufacturing site in Las Vegas, providing materials and contract manufacturing. Its services include sustainable hemp farming, extraction, in-house testing, wholesale raw materials, custom formulations, and private-label production. Based in Las Vegas, Nevada, the company serves brands and manufacturers seeking hemp-derived ingredients, formulation development, and private-label production. In March 2025 it launched CBT Isolate, reflecting ongoing product expansion, and it has previously expanded its European footprint with a distribution facility in the Netherlands.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
51-200

Section iconFunding & Financials

  • $1.5M

    GVB Biopharma has raised a total of $1.5M of funding over 1 rounds. Their latest funding round was raised on Nov 02, 2021 in the amount of $1.5M as a Debt Financing.

  • $25M - $50M

    GVB Biopharma's revenue is estimated to be in the range of $25M - $50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.